Hosted on MSN4h
Henry Schein extends gain on report of activist stake, push for board changes
A sale of the medical distribution business could increase Henry Schein's (HSIC) shares by 20%, while EPS could jump by ~35% ...
Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say
Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical ...
UBS: Henry Schein, Inc. (NASDAQ:HSIC) Is A Bottom-Ranked Quant Stock
We recently made a list of UBS’ Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors. In this piece, ...
Henry Schein’s Sell Rating: Internal Sales Weakness and Valuation Concerns Amidst Cybersecurity and Market Challenges
Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...